PEPFAR News and Research

RSS

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

This week, the U.S. Centers for Disease Control (CDC) Director, Dr. Tom Frieden, visited the Nigerian National TB and Leprosy Training Center (NTBLTC) to tour a multimillion dollar laboratory complex established by the Institute of Human Virology (IHV) of the University of Maryland School of Medicine in Baltimore, Maryland, and the Institute of Human Virology-Nigeria. This U.S.-Nigeria partnership was established in 2004 through funding from the CDC and the President's Emergency Plan For AIDS Relief (PEPFAR).

18 Jun 2010

Nurse-monitored ART found to be as safe, effective as therapy monitored by doctors in South African trial

"HIV drugs can be administered as effectively by nurses as by doctors, a finding that could yield major benefits in the fight against AIDS in Africa," according to a study published online Wednesday in the Lancet, Agence France-Presse reports.

18 Jun 2010

NPR's Morning Edition examines Global Health Initiative

NPR's Morning Edition examines the Obama administration's Global Health Initiative (GHI) and efforts to combat HIV/AIDS. The $63 billion dollar "initiative preserves the Bush AIDS relief plan," known as PEPFAR, and aims "to allow patients to get care at one location rather than having to seek care at different places. For example, family planning at one facility and HIV care at another," NPR notes.

18 Jun 2010

Opinions: Maintain fight against HIV/AIDS; Ending PMTCT; Impact of U.S. health reform on foreign-trained physicians

Following a recent trip to the largest HIV/AIDS clinic in Uganda, U.N. Secretary-General Ban Ki-Moon reflects on the recent progress made in the fight against the disease in a McClatchy opinion piece. Though "Uganda was the epicenter of the AIDS epidemic. …Uganda is also a success story," Ban writes. "A decade ago, fewer than 10,000 people were on the new generation of antiretroviral drugs that suppress the disease and offer the promise of a normal life.

17 Jun 2010

Opinions: Haitian housing; U.S. foreign aid

"The only thing that seems to be moving relentlessly ahead in Haiti is the weather, with punishing heat and near-daily thunderstorms settling in for the summer - and the hurricane season that just begun," according to a New York Times editorial highlighting some of the problems with the Haitian reconstruction effort.

14 Jun 2010

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

At a meeting which ended last night, the Executive Board of UNITAID approved a plan to step up efforts to enlist more countries to apply a solidarity levy on air tickets to provide additional funding for the health Millennium Development Goals. The Board approved a number of resolutions, among them the final phase of the establishment of a medicines patent pool, but a situation of depleting funds raises concerns for the many patients currently being treated by UNITAID.

11 Jun 2010

Recent releases in Global Health

A Lancet Infectious Diseases Leading Edge article examines the history of the global efforts to control polio and the challenges associated with targets to globally eradicate the disease. "The eradication of polio seems imminent, but with so few cases, there is a temptation to think an acceptable level of infection has been achieved. Not so.

29 May 2010

MSF report warns of effects of international donor 'backtracking' in global fight against HIV/AIDS

"Backtracking by international donors in funding for HIV/AIDS may undermine years of progress and is already putting lives at risk," according to a report released Thursday by Medecins Sans Frontieres, Reuters reports (Kelland, 5/27).

28 May 2010

Opinions: Gender-based violence and HIV; AIDS vaccine; Global NTDs; Responses to NYT HIV/AIDS articles

"Gender-based violence is a world-wide pandemic and directly affects the spread of HIV/AIDS. Fear of violence limits the ability of women and girls to choose their partners; to find out about a partner's HIV status or disclose their own; and to get medical or counseling services," according to a U.S. government editorial in VOA News.

19 May 2010

Recent releases in Global Health

As the 193 WHO member states gather at next week's World Health Assembly (WHA) "a draft global code of practice on the international recruitment of health personnel will be on the agenda. Negotiation and adoption of a WHO code of practice is an unprecedented opportunity to advance global consensus to address the critical challenges of migration of health workers and its effect on health systems worldwide," the authors of a Lancet Comment write.

15 May 2010

U.S. expands HIV/AIDS programs in Caribbean

Representatives from the U.S. and Caribbean Community (CARICOM) on Tuesday signed an agreement to expand PEPFAR programs to 12 other Caribbean nations during a gathering in Georgetown, Guyana, Agence France-Presse reports (5/11).

13 May 2010

Global efforts to combat HIV and AIDS confront changes as funding priorities shift

The New York Times detailed the current funding challenges facing the global effort to combat HIV and AIDS, using the country of Uganda as an example. "Uganda is the first and most obvious example of how the war on global AIDS is falling apart." Although this nation has made significant advances in what "some doctors call a 'golden window' for treatment," clinics are now routinely turning people away.

11 May 2010

New York Times examines global fight against HIV/AIDS

Several articles in the New York Times examine the global fight against HIV/AIDS. "Uganda is the first country where major clinics routinely turn people away" because they lack funding, the newspaper writes in an article that reports "money for [HIV/AIDS] treatment has stopped growing."

11 May 2010

Newsweek examines advocates' views of PEPFAR under Obama

Newsweek examines HIV/AIDS advocates' concerns that the Obama administration's focus on the six-year, $63 billion Global Health Initiative (GHI) is compromising PEPFAR's reach.

30 Apr 2010

Report looks at AIDS funding in developing countries

"A global pullback on commitments to fund and fight AIDS is resulting in restrictions on the number of people being enrolled into treatment programmes, more frequent drug shortages, and reduced national AIDS budgets," according to a report released Monday by the International Treatment Preparedness Coalition, BMJ News reports.

28 Apr 2010

Research documents early warning signs resulting from global pullback on AIDS funding

Rationing Funds, Risking Lives: World Backtracks on HIV Treatment, the new report from the International Treatment Preparedness Coalition, documents early warning signs resulting from the global pullback on AIDS commitment and funding: caps on the number of people enrolled in treatment programs, more frequent drug stock outs, and national AIDS budgets falling short.

26 Apr 2010

Recent releases in Global Health

"What is still needed [to fight malaria] is the only tool that has ever truly conquered any infectious disease: an effective and affordable vaccine. And here, the global malaria community has been too complacent," a Lancet editorial asserts in an article highlighting achievements and drawbacks in attempting to provide universal access to malaria prevention and treatment.

24 Apr 2010

FDA approves Lupin Pharmaceuticals' Imipramine Pamoate capsules

Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Imipramine Pamoate capsules, 75 mg, 100 mg, 125 mg and 150 mg strengths. Commercial shipments of the product have already commenced.

21 Apr 2010

Opinions: PEPFAR; Private-civil society partnerships in Africa; Global maternal mortality; SA HIV testing campaign

"The Obama administration's new Global Health Initiative, designed to broaden and better integrate health programming overseas, deserves wide support. But stalling on global AIDS threatens to undermine the worthy goals of the initiative," Chris Collins, vice president and director of public polity for the Foundation for AIDS Research, writes in a Boston Globe letter to the editor calling for sustained support for PEPFAR.

20 Apr 2010

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

19 Apr 2010

PEPFAR News and Research

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

Nurse-monitored ART found to be as safe, effective as therapy monitored by doctors in South African trial

NPR's Morning Edition examines Global Health Initiative

Opinions: Maintain fight against HIV/AIDS; Ending PMTCT; Impact of U.S. health reform on foreign-trained physicians

Opinions: Haitian housing; U.S. foreign aid

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

Recent releases in Global Health

MSF report warns of effects of international donor 'backtracking' in global fight against HIV/AIDS

Opinions: Gender-based violence and HIV; AIDS vaccine; Global NTDs; Responses to NYT HIV/AIDS articles

Recent releases in Global Health

U.S. expands HIV/AIDS programs in Caribbean

Global efforts to combat HIV and AIDS confront changes as funding priorities shift

New York Times examines global fight against HIV/AIDS

Newsweek examines advocates' views of PEPFAR under Obama

Report looks at AIDS funding in developing countries

Research documents early warning signs resulting from global pullback on AIDS funding

Recent releases in Global Health

FDA approves Lupin Pharmaceuticals' Imipramine Pamoate capsules

Opinions: PEPFAR; Private-civil society partnerships in Africa; Global maternal mortality; SA HIV testing campaign

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News